Customer Care

We are here to support you every step of the way!

Safety Data Sheets

Request COA/COC

Order Tracking

FAQs

  • What is the difference between the Prevantics Skin Antiseptic Swab (purple) and the Prevantics Device Swab (green)?

    While both products are composed of the same ingredients and use the same swab component, they require separate labeling. The two products have different indications and different directions for use. The Prevantics Skin Antiseptics swab is a drug and is intended for use on the skin whereas the Prevantics Device Swab is a medical device intended for use on needleless access sites.

  • Do PDI Unscented Baby Wipes contain parabens?

    No. All PDI Unscented Baby Wipes are paraben-free.

  • How long should I apply Sani-Hands® Instant Hand Sanitizing Wipes to the hands?

    A contact time of 15 seconds provides a 99.99% reduction.*

     

    *Reference is Data on File (C0211)

  • Are Sani-Hands® Instant Hand Sanitizing Wipes an FDA regulated product?

    Sani-Hands Instant Hand Sanitizing Wipes are regulated by the US FDA as an OTC (Over-the-Counter) drug product marketed under section 505G(a)(3).

  • When is the Profend® Nasal Antiseptic Kit used?

    The Profend Nasal Antiseptic Kit can be used on patients who have tested positive for S. aureus. As an alternative to a “test and treat” strategy, the ease and speed of application and economical design make Profend suitable for universal decolonization of all patients as well, saving time and money spent on patient testing. Regardless of decolonization strategy, Profend has proven efficacy—in a study of healthy volunteers, the Profend Nasal Antiseptic Kit reduced S. aureus by 99.7% in just 10 minutes.* For pre-operative use, clinicians can choose to apply the product to the patient at least 10 minutes prior to surgery depending on hospital protocol.

    *SOURCE: 1 PDI in vivo Study 0113-CTEVO.

  • How is the Profend® Nasal Antiseptic Kit used?

    The Profend Nasal Antiseptic Kit swabsticks are designed to be applied to the circumference of the patient’s nostril and anterior nares. In total, two swabsticks are applied to each nostril for 15 seconds per swabstick. Thus, using 4 swabsticks, the total treatment time is 60 seconds.

  • Why is the Profend® Nasal Antiseptic Kit used?

    Up to 30% of healthy adults are nasally colonized with S. aureus1. 85% of S. aureus SSIs come from the patient’s own nasal flora.2 Nasal colonization with these bacteria increases the patient risk of developing an SSI by 9 times.3 To help reduce this risk, Povidone-Iodine is used as a broad spectrum antiseptic that has proven efficacy in reducing S. aureus. It offers an added advantage over the widely-used nasal antibiotic, mupirocin, in that there is no known bacterial resistance to PVP-I, thereby supporting antibiotic stewardship within the healthcare environment.

     

    1 VandenBergh MF, Yzerman EP, van Belkum A, Boelens HA, Sijmons M, Verbrugh HA. Follow-up of Staphylococcus aureus nasal carriage after 8 years: redefining the persistent carrier state. J Clin Microbiol. 1999;37:3133–3140.

    2 Septimus EJ. Nasal Decolonization: What antimicrobials are more effective prior to surgery? Am J Infect Control 2019;47S:A53-A57. doi: 10.1016/j.ajic.2019.02.028.

    3 Kalmeijer MD, van Nieuw-land-Bollen E, Bogaers-Hofman D, de Baere GA. Nasal carriage of Staphylococcus aureus is a major risk factor for surgical-site infections in orthopedic surgery. Infect Control Hosp Epidemi-ol. 2000;21(15)319-323

  • Where is Prevantics® Device Swab used?

    Prevantics Device Swab can be used on needleless access sites—such as needleless ports, hubs, and connectors— which are used on vascular access devices including central venous catheters, PICC lines, midlines, and peripheral IVs.

  • How is Prevantics® Device Swab used?

    Prevantics Device Swab is designed to disinfect needleless access sites (i.e., “scrub the hub”) prior to use as well as in between each line access. Clinicians are directed to scrub the needleless access site for 5 seconds with back and forth strokes and then allow the site to dry for 5 seconds before accessing.

  • What evidence-based clinical guidelines support the use of the Prevantics® Device Swab for disinfection of needleless access sites prior to use?

    The following evidence-based clinical guidelines support the use of Chlorhexidine Gluconate/Alcohol for disinfection of needleless access sites prior to use:
    1. Guidelines for the Prevention of Intravascular Catheter-Related Infections, US Centers for Disease Control and Prevention (CDC)
    2. Standards of Practice, Infusion Nurses Society (INS)
    3. Strategies to Prevent Central-Line Associated Bloodstream Infections in Acute Care Hospitals, Society for Healthcare Epidemiology of America (SHEA/IDSA/APIC)
    4. National Patient Safety Goals, The Joint Commission
    5. Clinical Practice Guidelines for Diagnosis and Management of Intravascular Catheter-Related Infection, Infectious Disease Society of America (IDSA)
    6. Elimination Guide to Infections in Hemodialysis Settings, Association for Professionals in Infection Control and Epidemiology (APIC)

Need Help?